{"id":776,"date":"2025-01-26T02:27:04","date_gmt":"2025-01-26T02:27:04","guid":{"rendered":"https:\/\/finzexpert.com\/blog\/boeing-novo-nordisk-and-more\/"},"modified":"2025-01-26T02:27:04","modified_gmt":"2025-01-26T02:27:04","slug":"boeing-novo-nordisk-and-more","status":"publish","type":"post","link":"https:\/\/finzexpert.com\/blog\/boeing-novo-nordisk-and-more\/","title":{"rendered":"Boeing, Novo Nordisk and more"},"content":{"rendered":"\n<div id=\"RegularArticle-ArticleBody-5\" data-module=\"ArticleBody\"><span hidden=\"\" aria-hidden=\"true\" class=\"ArticleBody-extraData\"><span hidden=\"\" aria-hidden=\"true\" class=\"ArticleBody-extraData\"><span hidden=\"\" aria-hidden=\"true\" class=\"xyz-data\">These are some of the stocks posting the largest moves in premarket trading: Boeing \u2014 The airplane maker slipped 1.3% after preliminary fourth-quarter financial results reflected ongoing struggles. Boeing said it expects to report a loss of $5.46 per share for the fourth quarter on revenue of $15.2 billion, less than analysts&#8217; expectations, according to LSEG estimates. Boeing, which has not posted an annual profit since 2018, said it likely burned through $3.5 billion in cash during the quarter, partly due to a labor strike and new workforce agreement. Novo Nordisk \u2014 U.S.-listed shares jumped 14% after the Danish pharmaceutical maker said an early-stage trial for its once weekly amycretin obesity drug resulted in average weight reduction of 22% in obese and overweight patients after 36 weeks. Patients treated with the placebo saw 2% weight gain during the same period. Twilio \u2014 The cloud communications software maker issued an optimistic forecast for the next few years at a Thursday investor event, leading shares to rally almost 18%. Twilio said its adjusted operating margin will reach as high as 22% in 2027, above the Wall Street consensus and the latest quarter&#8217;s 16.1%. Baird upgraded the stock to an outperform rating from neutral\u00a0and said it came away from the company&#8217;s event confident ahead of its fourth-quarter results. CSX \u2014 The Jacksonville, Florida &#8211; based railroad slipped 3.5% after saying revenue fell last quarter due to a lower fuel surcharge and smaller coal revenue. CSX posted in-line earnings of 42 cents a share, excluding one-time items, which analysts polled by FactSet had expected. Revenue of $3.54 billion came in below the $3.56 billion forecast by analysts from FactSet. Texas Instruments \u2014 Shares slumped 4% after the semiconductor maker issued a disappointing earnings forecast. For the current quarter, Texas Instruments estimates profit will range from 94 cents to $1.16 per share, while analysts surveyed by LSEG had estimated $1.17 per share. In the quarter that just ended, however, Texas Instruments beat Street expectations for both earnings and revenue. Intuitive Surgical \u2014 The medical equipment maker fell 2% after a 2025 forecast showed one key profit margin is likely to shrink. Intuitive Surgical now expects an adjusted gross profit margin of 67% to 68% in 2025, down from 69.1% in 2024. \u2014 CNBC&#8217;s Lisa Han, Jesse Pound and Michelle Fox contributed reporting.<\/span><\/span><\/span><span class=\"HighlightShare-hidden\" style=\"top:0;left:0\"\/><\/p>\n<div class=\"InlineImage-imageEmbed\" id=\"ArticleBody-InlineImage-108072859\" data-test=\"InlineImage\">\n<div class=\"InlineImage-wrapper\">\n<div>\n<p>A production line of Wegovy injection pens for the Asian market at the Novo Nordisk A\/S pharmaceutical manufacturing facility in Hillerod, Denmark, on Nov. 27, 2024.<\/p>\n<p>Bloomberg | Bloomberg | Getty Images<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"group\">\n<p>These are some of the stocks posting the largest moves in premarket trading:<\/p>\n<p><span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"RegularArticle-QuoteInBody-1\">Boeing<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"\/><\/button><\/span><\/span><\/span> \u2014 The airplane maker slipped 1.3% after preliminary fourth-quarter\u00a0financial results reflected ongoing struggles. Boeing said it expects to report a loss of $5.46 per share for the fourth quarter on revenue of $15.2 billion, less than analysts&#8217; expectations, according to LSEG estimates. Boeing, which has not posted an annual profit since 2018, said it likely burned through $3.5 billion in cash during the quarter, partly due to a labor strike and new workforce agreement.<\/p>\n<p><span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"RegularArticle-QuoteInBody-3\">Novo Nordisk<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"\/><\/button><\/span><\/span><\/span> \u2014 U.S.-listed shares jumped 14% after the Danish pharmaceutical maker said an early-stage trial for its once weekly amycretin obesity drug resulted in average weight reduction of 22% in obese and overweight patients after 36 weeks. Patients treated with the placebo saw 2% weight gain during the same period.\u00a0\u00a0<\/p>\n<p><span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"RegularArticle-QuoteInBody-5\">Twilio<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"\/><\/button><\/span><\/span><\/span> \u2014 The cloud communications software maker issued an optimistic forecast for the next few years at a Thursday investor event, leading shares to rally almost 18%. Twilio said its adjusted operating margin will reach as high as 22% in 2027, above the Wall Street consensus and the latest quarter&#8217;s 16.1%. Baird upgraded the stock to an outperform rating from neutral\u00a0and said it came away from the company&#8217;s event confident ahead of its fourth-quarter results.<\/p>\n<p><span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"RegularArticle-QuoteInBody-8\">CSX<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"\/><\/button><\/span><\/span><\/span>\u00a0\u2014 The Jacksonville, Florida<em>&#8211;<\/em>based<em> <\/em>railroad slipped 3.5% after saying revenue fell last quarter due to a lower fuel surcharge and smaller coal revenue. CSX posted in-line earnings of 42 cents a share, excluding one-time items, which analysts polled by FactSet had expected. Revenue of $3.54 billion came in below the $3.56 billion forecast by analysts from FactSet.<\/p>\n<p><span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"RegularArticle-QuoteInBody-9\">Texas Instruments<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"\/><\/button><\/span><\/span><\/span> \u2014 Shares slumped 4% after the semiconductor maker issued a disappointing earnings forecast. For the current quarter, Texas Instruments estimates profit will range from 94 cents to $1.16 per share, while analysts surveyed by LSEG had estimated $1.17 per share. In the quarter that just ended, however, Texas Instruments beat Street expectations for both earnings and revenue.<\/p>\n<p><span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"RegularArticle-QuoteInBody-10\">Intuitive Surgical<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"\/><\/button><\/span><\/span><\/span> \u2014 The medical equipment maker fell 2% after a 2025 forecast showed one key profit margin is likely to shrink. Intuitive Surgical now expects an adjusted gross profit margin of 67% to 68% in 2025, down from 69.1% in 2024.<\/p>\n<p><em>\u2014 CNBC&#8217;s Lisa Han, Jesse Pound and Michelle Fox contributed reporting.<\/em><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>These are some of the stocks posting the largest moves in premarket trading: Boeing \u2014 The airplane maker slipped 1.3% after preliminary fourth-quarter financial results reflected ongoing struggles. Boeing said it expects to report a loss of $5.46 per share for the fourth quarter on revenue of $15.2 billion, less than analysts&#8217; expectations, according to [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":777,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[538,540,539],"class_list":["post-776","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-loan","tag-boeing","tag-nordisk","tag-novo"],"_links":{"self":[{"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/posts\/776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/comments?post=776"}],"version-history":[{"count":0,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/posts\/776\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/media\/777"}],"wp:attachment":[{"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/media?parent=776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/categories?post=776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/tags?post=776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}